Quick Takeaways: Why It Matters? Cronus Pharma’s launch of Florfinasone Otic (florfenicol + terbinafine + mometasone) adds an FDA‑approved, single‑use, triple‑action topical for canine otitis externa to a growing companion‑animal ear‑infection market. The fixed‑dose combination...
Quick Takeaways: Why It Matters? Zenex’s acquisition of SAVA’s SAVAVET companion‑animal business (~70 brands; ~165 stockists; relationships with 6,000+ veterinarians) instantly scales its pet‑care franchise in India—one of the fastest‑growing animal‑health segments driven by ri...
Quick Takeaways: Why It Matters? Dechra has launched Laverdia (verdinexor tablets), the first and only FDA‑approved oral treatment for dogs with lymphoma, enabling at‑home therapy that can start on Day 1 after diagnosis. Canine lymphoma is one of the most common cancers i...
Quick Takeaways: Why It Matters? The FDA’s Emergency Use Authorization for Bimectin (ivermectin) Injection adds a second over‑the‑counter option for preventing New World screwworm in cattle, alongside the pioneer Ivomec product, and is intended to ...
Quick Takeaways: Why It Matters? Elanco’s $120M expansion of its Elwood, Kansas site quadruples monoclonal antibody capacity and adds upstream/downstream processing, a pilot plant and QC lab, directly supporting its new biologics franchise (Befrena&nbs...
Quick Takeaways: Why It Matters? Cronus Pharma’s launch of Robenacoxib Injection gives US veterinarians the first FDA‑approved bioequivalent to Onsior (robenacoxib) Injection, providing a cost‑effective, short‑term NSAID option for postoperative pain an...
Dechra Launches Domidine Equine Sedative in the US Quick Takeaways: Why It Matters? Dechra’s US launch of Domidine (detomidine) adds a generic, cost‑effective alpha‑2 agonist to the equine sedation market, giving veterina...
Quick Takeaways: Why It Matters? The FDA’s Emergency Use Authorization for Simparica Trio to treat New World screwworm (NWS) larvae in dogs gives veterinarians a convenient, oral option that can be used alongside existing livestock tools (e.g., Dectomax...
Quick Takeaways: Why It Matters? ECO’s licence of Vaxinano’s late‑stage sheep toxoplasmosis vaccine gives it a low‑cost, de‑risked way to add a high‑value preventative product that directly tackles a major cause of abortion and lamb losses, with peak sales estimated a...
Quick Takeaways: Why It Matters? The authorization expands Elanco’s screwworm portfolio beyond Negasunt Powder and Tanidil (earlier emergency tools) and complements EPA‑registered Catron IV, creating a more complete prevention-plus-treatment toolkit as USDA tracks dozens of animal cases an...
